Kim Forest Competitors and Similar CompaniesClear all
Kim Forest's competitors and similar companies include Lutonix and Intra-Cellular Therapies.
 Kim Forest Kim Forest (金萬林企業股份有限公司) is a company that develops, manufactures, and sells biomedical products. |  Lutonix Lutonix DCB is a new drug-coated balloon catheter that delivers paclitaxel to the arterial wall in a single, short inflation. |  Intra-Cellular Therapies Intra-Cellular Therapies develops drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the CNS. | |
Founding Date | Founding Date 2004 | Founding Date 2007 | Founding Date 2002 |
Type | Type Public | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations HQ | Locations Maple Grove, US HQ | Locations New York, US HQ |
Employees | Employees N/A | Employees 10 | Employees 330352% increase |
Financial | |||
Revenue (est.) | Revenue (est.) NT$549.1m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $680.9m (FY, 2024) |
Net income | Net income (NT$148m) (FY, 2025) | Net income N/A | Net income ($74.7m) (FY, 2024) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 35m | Total funding raised $ 225.3m |
For sources of this data, please see the company profile
View Company Profiles
Lutonix
HQ
Maple Grove, US
Lutonix DCB is a new drug-coated balloon catheter that delivers paclitaxel to the arterial wall in a single, short inflation.
View companyIntra-Cellular Therapies
HQ
New York, US
Employees
330
Intra-Cellular Therapies develops drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the CNS.
View company